{
    "applicationNumber": "BR 11 2012 000370-4",
    "filingDate": "08/07/2010",
    "grantDate": null,
    "title": "DERIVADOS DE 1,2,4-TIAZOLIDIN-3-ONA E SEUS USOS NO TRATAMENTO DE C\u00c2NCER",
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "61/213,735",
            "priorityDate": "08/07/2009"
        }
    ],
    "events": [
        {
            "code": "7.5",
            "description": "Notifica\u00e7\u00e3o de Anu\u00eancia relacionada com o Art. 229-C da LPI",
            "bulletinNumber ": "2482"
        },
        {
            "code": "6.1",
            "description": "Exig\u00eancia T\u00e9cnica",
            "bulletinNumber ": "2493"
        },
        {
            "code": "9.1",
            "description": "Deferimento",
            "bulletinNumber ": "2510"
        },
        {
            "code": "16.1",
            "description": "Concess\u00e3o de Patente ou Certificado de Adi\u00e7\u00e3o de Inven\u00e7\u00e3o",
            "bulletinNumber ": "2519"
        }
    ],
    "inventors": [
        "JACOB WESTMAN",
        "ALLAN HALLETT",
        "JAN VAGBERG"
    ],
    "holders": [
        79524
    ],
    "ipcCodes": [
        "C07D 285/08",
        "C07D 417/12",
        "A61K 31/433",
        "C07D 417/10"
    ]
}